Active — Not RecruitingNot Applicable

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

Ireland72 participantsStarted 2023-05-08

Plain-language summary

To evaluate the feasibility of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary malignancies.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men aged ≥ 18 years of age at the time of study enrolment.
✓. Willing to participate in a 12-week intervention programme and follow up procedures as outlined in the Schedule of Activities section.
✓. ECOG performance status 0-2.
✓. Recovery to CTCAE Grade ≤2 adverse events from all prior therapies, or adequately recovered adverse events whereby, whereby the PI feels they will not impact the participants ability to complete the 12-week intervention.
✓. Disease-specific inclusion criteria:
✓. Participation in other translational or interventional clinical trials is permitted provided the above disease-specific inclusion criteria are met.
✓. Signed consent form by the participant or a legally authorized representative (LAR).

Exclusion criteria

✕. Persons who, in the opinion of the researcher or supervising clinician, are unable to cooperate adequately with the study protocol, for example those receiving systemic therapy for a concurrent cancer diagnosis, those with organ system dysfunction which would impact their safe participation in the study, or other uncontrolled medical illness that would impact their safe participation in the study.
✕. Recent (within 12 months) participation in a study/programme involving a lifestyle intervention (e.g diet, exercise, survivorship).
✕. Note: Per discretion of PI as to whether may impact the outcome of this study intervention.

What they're measuring

Feasibility as assessed by a purposefully designed feasibility questionnaire

Timeframe: At week 12

Feasibility as assessed by a purposefully designed feasibility questionnaire

Timeframe: At 6-month post intervention timepoint

The acceptability of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary cancer

Timeframe: At week 12

The acceptability of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary cancer

Timeframe: At the 6-month post intervention timepoint

Trial details

NCT IDNCT05946993

SponsorUniversity College Cork

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Survivorship trials

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men aged ≥ 18 years of age at the time of study enrolment.
✓. Willing to participate in a 12-week intervention programme and follow up procedures as outlined in the Schedule of Activities section.
✓. ECOG performance status 0-2.
✓. Recovery to CTCAE Grade ≤2 adverse events from all prior therapies, or adequately recovered adverse events whereby, whereby the PI feels they will not impact the participants ability to complete the 12-week intervention.
✓. Disease-specific inclusion criteria:
✓. Participation in other translational or interventional clinical trials is permitted provided the above disease-specific inclusion criteria are met.
✓. Signed consent form by the participant or a legally authorized representative (LAR).

Exclusion criteria

✕. Persons who, in the opinion of the researcher or supervising clinician, are unable to cooperate adequately with the study protocol, for example those receiving systemic therapy for a concurrent cancer diagnosis, those with organ system dysfunction which would impact their safe participation in the study, or other uncontrolled medical illness that would impact their safe participation in the study.
✕. Recent (within 12 months) participation in a study/programme involving a lifestyle intervention (e.g diet, exercise, survivorship).
✕. Note: Per discretion of PI as to whether may impact the outcome of this study intervention.

What they're measuring

Feasibility as assessed by a purposefully designed feasibility questionnaire

Timeframe: At week 12

Feasibility as assessed by a purposefully designed feasibility questionnaire

Timeframe: At 6-month post intervention timepoint

The acceptability of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary cancer

Timeframe: At week 12

The acceptability of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary cancer

Timeframe: At the 6-month post intervention timepoint